Cardinal Health unit seeks tax breaks for local drug facility

Back to TopCommentsE-mailPrintBookmark and Share

A subsidiary of Dublin, Ohio-based Cardinal Health Inc. is seeking tax breaks from the city of Indianapolis to help it open a $14.4 million local drug-production facility that would employ 85 workers by 2017.

Cardinal Health 414 LLC produces a cancer treatment locally at a compounding center on Georgetown Road. The Indianapolis Department of Metropolitan Development said Cardinal wants to expand production of the medication by opening a second facility in an existing 64,000-square-foot warehouse at 4343 W. 62nd St.

DMD staff said the company also is evaluating a potential site in Colorado.

If the project goes forward locally, the company said it would spend $11.5 million to make the building suitable for pharmaceutical production and another $2.9 million in manufacturing and research equipment for the facility.

The plant would eventually employ 85 workers making an average of wage of $30 per hour, the company said.

DMD staff support a tax abatement on real property that would save the company $529,519 over 10 years. During that time, the company still would pay $540,216 in property taxes.

After the abatement period ends, the company would pay an estimated $107,000 in property taxes, in addition to $61,000 currently paid on the property.

In addition, DMD staff backs a 10-year personal-property tax abatement related to new equipment that would save the company $160,778. Cardinal would still pay $107,953 in personal property taxes during that time, plus an estimated $23,034 annually after the abatement period.

The Indianapolis Metropolitan Development Commission will consider the incentives at a Wednesday meeting. If approved, they would move to a public hearing scheduled for Sept. 3.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ